BIAFVSNMRA• 3 Months (Normalized)
BIAF vs NMRA (bioAffinity Technologies Inc. vs Neumora Therapeutics Inc.)
Showing Closing Date Range from Jun, 13 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BIAF Performance $7.95
-61.31%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
NMRA Performance $1.04
+13.66%
Neumora Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin NMRA LEADS
-74.97%
NMRA outperforming by 74.97%
BIAFNMRA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BIAF NMRA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BIAF Price | BIAF Gain (%) | NMRA Price | NMRA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $7.95 | -61.31% | $1.04 | +13.66% | -74.97% |
| Sep 10, 2026 | $9.39 | -54.31% | $1.14 | +24.59% | -78.90% |
| Sep 09, 2026 | $10.50 | -48.91% | $1.20 | +31.15% | -80.06% |
| Sep 08, 2026 | $8.93 | -56.55% | $1.25 | +36.61% | -93.16% |
| Sep 04, 2026 | $15.27 | -25.69% | $1.31 | +43.17% | -68.86% |
| Sep 03, 2026 | $12.78 | -37.81% | $1.35 | +47.54% | -85.35% |
| Sep 02, 2026 | $9.75 | -52.55% | $1.38 | +50.82% | -103.37% |
| Sep 01, 2026 | $6.59 | -67.93% | $1.33 | +45.36% | -113.29% |
| Aug 31, 2026 | $4.56 | -77.81% | $1.33 | +45.36% | -123.17% |
| Aug 28, 2026 | $4.87 | -76.30% | $1.39 | +51.91% | -128.21% |
| Aug 27, 2026 | $5.06 | -75.38% | $1.48 | +61.75% | -137.13% |
| Aug 26, 2026 | $5.09 | -75.23% | $1.56 | +70.49% | -145.72% |
| Aug 25, 2026 | $5.19 | -74.74% | $1.50 | +63.93% | -138.67% |
| Aug 24, 2026 | $5.82 | -71.68% | $1.53 | +66.67% | -138.35% |
| Aug 21, 2026 | $6.00 | -70.80% | $1.63 | +78.14% | -148.94% |
Page 1 of 5